153 related articles for article (PubMed ID: 19896317)
1. Quantification of sunitinib in mouse plasma, brain tumor and normal brain using liquid chromatography-electrospray ionization-tandem mass spectrometry and pharmacokinetic application.
Zhou Q; Gallo JM
J Pharm Biomed Anal; 2010 Mar; 51(4):958-64. PubMed ID: 19896317
[TBL] [Abstract][Full Text] [Related]
2. Bioanalytical method for the quantification of sunitinib and its n-desethyl metabolite SU12662 in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometry.
de Bruijn P; Sleijfer S; Lam MH; Mathijssen RH; Wiemer EA; Loos WJ
J Pharm Biomed Anal; 2010 Mar; 51(4):934-41. PubMed ID: 19931354
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.
Rais R; Zhao M; He P; Xu L; Deeken JF; Rudek MA
Biomed Chromatogr; 2012 Nov; 26(11):1315-24. PubMed ID: 22259028
[TBL] [Abstract][Full Text] [Related]
4. Determination of sunitinib and its active metabolite, N-desethyl sunitinib in mouse plasma and tissues by UPLC-MS/MS: assay development and application to pharmacokinetic and tissue distribution studies.
Chen X; Wang Z; Liu M; Liao M; Wang X; Du H; Chen J; Yao M; Li Q
Biomed Chromatogr; 2015 May; 29(5):679-88. PubMed ID: 25294592
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a liquid chromatography/tandem mass spectrometry procedure for the quantification of sunitinib (SU11248) and its active metabolite, N-desethyl sunitinib (SU12662), in human plasma: application to an explorative study.
Rodamer M; Elsinghorst PW; Kinzig M; Gütschow M; Sörgel F
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(11-12):695-706. PubMed ID: 21367676
[TBL] [Abstract][Full Text] [Related]
6. Determination of a novel carbamate AChE inhibitor meserine in mouse plasma, brain and rat plasma by LC-MS/MS: application to pharmacokinetic study after intravenous and subcutaneous administration.
Xie Y; Jiang P; Ge X; Wang H; Shao B; Xie Q; Qiu Z; Chen H
J Pharm Biomed Anal; 2014 Aug; 96():156-61. PubMed ID: 24747147
[TBL] [Abstract][Full Text] [Related]
7. Quantification of sunitinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
Minkin P; Zhao M; Chen Z; Ouwerkerk J; Gelderblom H; Baker SD
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Oct; 874(1-2):84-8. PubMed ID: 18823825
[TBL] [Abstract][Full Text] [Related]
8. Determination of 5-HT receptor antagonists, MEFWAY and MPPF using liquid chromatography electrospray ionization tandem mass spectrometry in rat plasma and brain tissue.
Zheng Z; Lee BH; Choi JY; Ryu YH; Bae MA; Ahn SH
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jan; 913-914():24-9. PubMed ID: 23266361
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of sunitinib and its two metabolites in plasma of Chinese patients with metastatic renal cell carcinoma by liquid chromatography-tandem mass spectrometry.
Qiu F; Bian W; Li J; Ge Z
Biomed Chromatogr; 2013 May; 27(5):615-21. PubMed ID: 23108983
[TBL] [Abstract][Full Text] [Related]
10. A rapid and sensitive LC-MS/MS assay to quantify yonkenafil in rat plasma with application to preclinical pharmacokinetics studies.
Wang J; Jiang Y; Wang Y; Tang Y; Teng G; Fawcett JP; Kong J; Gu J
J Pharm Biomed Anal; 2008 Aug; 47(4-5):985-9. PubMed ID: 18499386
[TBL] [Abstract][Full Text] [Related]
11. Quantification of sunitinib and N-desethyl sunitinib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry: validation and application in routine therapeutic drug monitoring.
Lankheet NA; Steeghs N; Rosing H; Schellens JH; Beijnen JH; Huitema AD
Ther Drug Monit; 2013 Apr; 35(2):168-76. PubMed ID: 23503442
[TBL] [Abstract][Full Text] [Related]
12. A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine.
Marangon E; Buzzo M; Posocco B; Gagno S; Zanchetta M; Iacuzzi V; Poetto AS; Guardascione M; Giodini L; Toffoli G
J Pharm Biomed Anal; 2020 Feb; 179():112949. PubMed ID: 31784210
[TBL] [Abstract][Full Text] [Related]
13. Determination of total and unbound ribociclib in human plasma and brain tumor tissues using liquid chromatography coupled with tandem mass spectrometry.
Bao X; Wu J; Sanai N; Li J
J Pharm Biomed Anal; 2019 Mar; 166():197-204. PubMed ID: 30660034
[TBL] [Abstract][Full Text] [Related]
14. Liquid chromatography-electrospray ionization-tandem mass spectrometry method for quantitative estimation of new imiqualine leads with potent anticancer activities in rat and mouse plasma. Application to a pharmacokinetic study in mice.
Chouchou A; Marion B; Enjalbal C; Roques C; Cuq P; Bonnet PA; Bressolle-Gomeni FMM; Deleuze-Masquéfa C
J Pharm Biomed Anal; 2018 Jan; 148():369-379. PubMed ID: 29111492
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS.
Andriamanana I; Gana I; Duretz B; Hulin A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 926():83-91. PubMed ID: 23562906
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model.
Zhou Q; Gallo JM
Neuro Oncol; 2009 Jun; 11(3):301-10. PubMed ID: 18971416
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a highly sensitive LC-MS/MS method for determination of brain active agent dianhydrogalactitol in mouse plasma and tissues: Application to a pharmacokinetic study.
Sun L; Wu H; Ren L; Cong J; Qin X; Wang X; Qi X; Kang L; Zhang J; Wu C
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1087-1088():90-97. PubMed ID: 29730531
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of SU5416 and its phase I and phase II metabolites in rat and dog plasma by LC/MS/MS.
Zhao Y; Yang CY; Haznedar J; Antonian L
J Pharm Biomed Anal; 2001 Jul; 25(5-6):821-32. PubMed ID: 11377065
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitative determination of gamithromycin in animal plasma, lung tissue and pulmonary epithelial lining fluid.
De Baere S; Devreese M; Watteyn A; Wyns H; Plessers E; De Backer P; Croubels S
J Chromatogr A; 2015 Jun; 1398():73-82. PubMed ID: 25937131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
